Your browser doesn't support javascript.
loading
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015.
Dalle, J-H; Lucchini, G; Balduzzi, A; Ifversen, M; Jahnukainen, K; Macklon, K T; Ahler, A; Jarisch, A; Ansari, M; Beohou, E; Bresters, D; Corbacioglu, S; Dalissier, A; Diaz de Heredia Rubio, C; Diesch, T; Gibson, B; Klingebiel, T; Lankester, A; Lawitschka, A; Moffat, R; Peters, C; Poirot, C; Saenger, N; Sedlacek, P; Trigoso, E; Vettenranta, K; Wachowiak, J; Willasch, A; von Wolff, M; Yaniv, I; Yesilipek, A; Bader, P.
Afiliación
  • Dalle JH; Department of Hemato-immunology, Robert-Debre Hospital, APHP, Paris-Diderot University, Paris, France.
  • Lucchini G; Department of Bone Marrow Transplant, Great Ormond Street Hospital, London, UK.
  • Balduzzi A; Clinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione Monza e Brianza per il Bambino e la sua Mamma, Ospedale San Gerardo di Monza, Monza, Italy.
  • Ifversen M; Department of Pediatric and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Jahnukainen K; Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Macklon KT; Department of Women's and Children's Health, Karolinska Institute, University Hospital, Stockholm, Sweden.
  • Ahler A; The Fertility Clinic, Section 4071, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
  • Jarisch A; Clinic for Gynaecologic Endocrinology and Reproductive Medicine, University Hospital, Basel, Switzerland.
  • Ansari M; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Beohou E; Department of Pediatrics, Onco-Hematology Unit, Geneva University Hospitals, Geneva, Switzerland.
  • Bresters D; CANSEARCH Research Laboratory, Geneva University, Geneva, Switzerland.
  • Corbacioglu S; EBMT Paris Office, Hospital Saint Antoine, Paris, France.
  • Dalissier A; Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
  • Diaz de Heredia Rubio C; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital, University of Regensburg, Regensburg, Germany.
  • Diesch T; EBMT Paris Office, Hospital Saint Antoine, Paris, France.
  • Gibson B; Department of Pediatric Oncology and Hematology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Klingebiel T; Division of Paediatric Oncology/Haematology, University Children's Hospital of Basel, Basel, Switzerland.
  • Lankester A; Department of Paediatric Haematology, Royal Hospital for Children, Glasgow, UK.
  • Lawitschka A; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Moffat R; Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
  • Peters C; St Anna Children's Hospital, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien, Vienna, Austria.
  • Poirot C; Clinic for Gynaecologic Endocrinology and Reproductive Medicine, University Hospital, Basel, Switzerland.
  • Saenger N; St Anna Children's Hospital, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien, Vienna, Austria.
  • Sedlacek P; Adolescents and Young Adults Hematology Unit, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, University Pierre et Marie Curie, Paris, France.
  • Trigoso E; Division for Reproductive Endocrinology and Infertility, Department for Gynecology and Obstetrics, University Hospital, Frankfurt, Germany.
  • Vettenranta K; Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic.
  • Wachowiak J; Paediatric Oncology Unit, Paediatric Transplant Unit, Polytechnic and University Hospital 'LA FE', Valencia, Spain.
  • Willasch A; Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
  • von Wolff M; Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland.
  • Yaniv I; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Yesilipek A; Division of Reproductive Medicine and Endocrinology, Department of Obstetrics and Gynaecology, Inselspital Bern, University Hospital, Bern, Switzerland.
  • Bader P; Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Bone Marrow Transplant ; 52(7): 1029-1035, 2017 Jul.
Article en En | MEDLINE | ID: mdl-28287638
Nowadays, allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a well-established treatment procedure and often the only cure for many patients with malignant and non-malignant diseases. Decrease in short-term complications has substantially contributed to increased survival. Therefore long-term sequelae are reaching the focus of patient care. One of the most important risks of stem cell transplant survivors is infertility. As well as in the field of allo-HSCT also the field of reproductive medicine has achieved substantial advances to offer potential options for fertility preservation in both boys and girls. Access to these procedures as well as their financing differs significantly throughout Europe. As all European children and adolescents should have the same possibility, the Paediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation organised an expert meeting in September 2015. This manuscript describes the recommendations for the diagnosis and pre-emptive procedures that should be offered to all children and adolescents in Europe who have to undergo an allo-HSCT.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Fertilidad / Infertilidad Femenina / Infertilidad Masculina Tipo de estudio: Guideline Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Fertilidad / Infertilidad Femenina / Infertilidad Masculina Tipo de estudio: Guideline Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido